Successful management of synchronous recurrent breast carcinoma with chronic myelogenous leukemia: a case report View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2017-01-10

AUTHORS

Choukri Elm’hadi, Mohamed Reda Khmamouche, Rachid Tanz, Mehdi Toreis, ElMehdi Mahtat, Mohammed Allaoui, Mohammed Oukabli, Nezha Messaoudi, Hassan Errihani, Mohammed Ichou

ABSTRACT

BackgroundSurvival is increasing after early breast cancer revealing frequent relapses and possibility of developing secondary malignancies. The concomitant occurrence of these two events is exceptionally disastrous and lethal. We report a case of a Moroccan woman who was successfully managed for synchronous recurrent breast carcinoma and chronic myelogenous leukemia.Case presentationA 42-year-old Moroccan woman was diagnosed with localized breast carcinoma in 2008. She received six cycles of an adjuvant chemotherapy regimen, radiation therapy and hormonal therapy by tamoxifen. After completion of 5 years of tamoxifen our patient reported asthenia; a physical examination found hepatomegaly, massive splenomegaly measuring 21 cm and supraclavicular lymphadenopathy. The staging showed lung and liver metastases. Morphology and immunohistochemical profile of this metastasis identified an adenocarcinoma of mammary origin. In parallel, the diagnosis of chronic myeloid leukemia was suspected because of the presence of a leukocytosis at 355 × 109/L, with circulating blasts of 4%. Chronic myeloid leukemia was confirmed by a bone marrow biopsy with the presence of Ph chromosome on cytogenetical analysis.Daily imatinib was ordered concurrently with chemotherapy-type docetaxel. The metastases were stable after nine courses of chemotherapy. Due to breast cancer progression 4 months later, bevacizumab and capecitabine were introduced.A major molecular response was achieved after 12 and 18 months. She has now completed 2 years of follow-up, still on a major molecular response, and is undergoing imatinib and capecitabine treatment.ConclusionsLeukocytosis in breast cancer patients can reveal chronic myeloid leukemia. It may warrant a workup to find the underlying etiology, which could include a secondary hematological malignancy. More... »

PAGES

10

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s13256-016-1180-4

DOI

http://dx.doi.org/10.1186/s13256-016-1180-4

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1039203116

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/28069070


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Combined Chemotherapy Protocols", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Breast Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Capecitabine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Chemotherapy, Adjuvant", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Docetaxel", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Imatinib Mesylate", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Leukemia, Myelogenous, Chronic, BCR-ABL Positive", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm Recurrence, Local", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Taxoids", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "School of Medicine and Pharmacy, University Mohamed V, Souissi, Rabat, Morocco", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Medical Oncology Department, Mohammed V Military Teaching Hospital of Rabat, Rabat, Morocco", 
            "School of Medicine and Pharmacy, University Mohamed V, Souissi, Rabat, Morocco"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Elm\u2019hadi", 
        "givenName": "Choukri", 
        "id": "sg:person.01050464377.90", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01050464377.90"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Medical Oncology Department, Mohammed V Military Teaching Hospital of Rabat, Rabat, Morocco", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Medical Oncology Department, Mohammed V Military Teaching Hospital of Rabat, Rabat, Morocco"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Khmamouche", 
        "givenName": "Mohamed Reda", 
        "id": "sg:person.01306745267.40", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01306745267.40"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Medical Oncology Department, Mohammed V Military Teaching Hospital of Rabat, Rabat, Morocco", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Medical Oncology Department, Mohammed V Military Teaching Hospital of Rabat, Rabat, Morocco"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tanz", 
        "givenName": "Rachid", 
        "id": "sg:person.0610414050.24", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0610414050.24"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Medical Oncology Department, Mohammed V Military Teaching Hospital of Rabat, Rabat, Morocco", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Medical Oncology Department, Mohammed V Military Teaching Hospital of Rabat, Rabat, Morocco"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Toreis", 
        "givenName": "Mehdi", 
        "id": "sg:person.0755507243.30", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0755507243.30"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Clinical Hematology Department, Mohammed V Military Teaching Hospital of Rabat, Rabat, Morocco", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Clinical Hematology Department, Mohammed V Military Teaching Hospital of Rabat, Rabat, Morocco"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mahtat", 
        "givenName": "ElMehdi", 
        "id": "sg:person.01273516024.18", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01273516024.18"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pathology, Mohammed V Military Teaching Hospital of Rabat, Rabat, Morocco", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Pathology, Mohammed V Military Teaching Hospital of Rabat, Rabat, Morocco"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Allaoui", 
        "givenName": "Mohammed", 
        "id": "sg:person.01057303445.83", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01057303445.83"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pathology, Mohammed V Military Teaching Hospital of Rabat, Rabat, Morocco", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Pathology, Mohammed V Military Teaching Hospital of Rabat, Rabat, Morocco"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Oukabli", 
        "givenName": "Mohammed", 
        "id": "sg:person.01307760445.85", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01307760445.85"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Laboratory of Hematology, Mohammed V Military Teaching Hospital of Rabat, Rabat, Morocco", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Laboratory of Hematology, Mohammed V Military Teaching Hospital of Rabat, Rabat, Morocco"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Messaoudi", 
        "givenName": "Nezha", 
        "id": "sg:person.01064507530.79", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01064507530.79"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Medical Oncology Department, National Institute of Oncology Sidi Mohamed Ben Abdellah, Rabat, Morocco", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Medical Oncology Department, National Institute of Oncology Sidi Mohamed Ben Abdellah, Rabat, Morocco"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Errihani", 
        "givenName": "Hassan", 
        "id": "sg:person.01105351647.11", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01105351647.11"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Medical Oncology Department, Mohammed V Military Teaching Hospital of Rabat, Rabat, Morocco", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Medical Oncology Department, Mohammed V Military Teaching Hospital of Rabat, Rabat, Morocco"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ichou", 
        "givenName": "Mohammed", 
        "id": "sg:person.015315714724.06", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015315714724.06"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s10549-006-9460-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000430722", 
          "https://doi.org/10.1007/s10549-006-9460-0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrclinonc.2010.154", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008665386", 
          "https://doi.org/10.1038/nrclinonc.2010.154"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1757-1626-3-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038578733", 
          "https://doi.org/10.1186/1757-1626-3-4"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2017-01-10", 
    "datePublishedReg": "2017-01-10", 
    "description": "BackgroundSurvival is increasing after early breast cancer revealing frequent relapses and possibility of developing secondary malignancies. The concomitant occurrence of these two events is exceptionally disastrous and lethal. We report a case of a Moroccan woman who was successfully managed for synchronous recurrent breast carcinoma and chronic myelogenous leukemia.Case presentationA 42-year-old Moroccan woman was diagnosed with localized breast carcinoma in 2008. She received six cycles of an adjuvant chemotherapy regimen, radiation therapy and hormonal therapy by tamoxifen. After completion of 5 years of tamoxifen our patient reported asthenia; a physical examination found hepatomegaly, massive splenomegaly measuring 21 cm and supraclavicular lymphadenopathy. The staging showed lung and liver metastases. Morphology and immunohistochemical profile of this metastasis identified an adenocarcinoma of mammary origin. In parallel, the diagnosis of chronic myeloid leukemia was suspected because of the presence of a leukocytosis at 355 \u00d7 109/L, with circulating blasts of 4%. Chronic myeloid leukemia was confirmed by a bone marrow biopsy with the presence of Ph chromosome on cytogenetical analysis.Daily imatinib was ordered concurrently with chemotherapy-type docetaxel. The metastases were stable after nine courses of chemotherapy. Due to breast cancer progression 4 months later, bevacizumab and capecitabine were introduced.A major molecular response was achieved after 12 and 18 months. She has now completed 2 years of follow-up, still on a major molecular response, and is undergoing imatinib and capecitabine treatment.ConclusionsLeukocytosis in breast cancer patients can reveal chronic myeloid leukemia. It may warrant a workup to find the underlying etiology, which could include a secondary hematological malignancy.", 
    "genre": "article", 
    "id": "sg:pub.10.1186/s13256-016-1180-4", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1038062", 
        "issn": [
          "1752-1947"
        ], 
        "name": "Journal of Medical Case Reports", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "11"
      }
    ], 
    "keywords": [
      "chronic myeloid leukemia", 
      "major molecular response", 
      "recurrent breast carcinoma", 
      "chronic myelogenous leukemia", 
      "breast carcinoma", 
      "myeloid leukemia", 
      "myelogenous leukemia", 
      "adjuvant chemotherapy regimen", 
      "years of tamoxifen", 
      "courses of chemotherapy", 
      "early breast cancer", 
      "breast cancer patients", 
      "bone marrow biopsy", 
      "secondary hematological malignancies", 
      "Moroccan women", 
      "daily imatinib", 
      "chemotherapy regimen", 
      "hormonal therapy", 
      "supraclavicular lymphadenopathy", 
      "capecitabine treatment", 
      "frequent relapses", 
      "Case presentationA", 
      "liver metastases", 
      "secondary malignancies", 
      "massive splenomegaly", 
      "marrow biopsy", 
      "physical examination", 
      "cancer patients", 
      "case report", 
      "immunohistochemical profile", 
      "breast cancer", 
      "radiation therapy", 
      "hematological malignancies", 
      "molecular response", 
      "mammary origin", 
      "Ph chromosome", 
      "leukemia", 
      "carcinoma", 
      "concomitant occurrence", 
      "metastasis", 
      "successful management", 
      "patients", 
      "tamoxifen", 
      "malignancy", 
      "imatinib", 
      "therapy", 
      "months", 
      "women", 
      "BackgroundSurvival", 
      "lymphadenopathy", 
      "bevacizumab", 
      "hepatomegaly", 
      "leukocytosis", 
      "capecitabine", 
      "regimen", 
      "asthenia", 
      "splenomegaly", 
      "relapse", 
      "chemotherapy", 
      "adenocarcinoma", 
      "biopsy", 
      "docetaxel", 
      "lung", 
      "etiology", 
      "workup", 
      "years", 
      "cancer", 
      "staging", 
      "diagnosis", 
      "response", 
      "cytogenetical analysis", 
      "treatment", 
      "examination", 
      "report", 
      "presence", 
      "blasts", 
      "course", 
      "completion", 
      "management", 
      "cases", 
      "occurrence", 
      "events", 
      "profile", 
      "analysis", 
      "origin", 
      "cycle", 
      "possibility", 
      "parallel", 
      "chromosomes", 
      "morphology"
    ], 
    "name": "Successful management of synchronous recurrent breast carcinoma with chronic myelogenous leukemia: a case report", 
    "pagination": "10", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1039203116"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s13256-016-1180-4"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "28069070"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s13256-016-1180-4", 
      "https://app.dimensions.ai/details/publication/pub.1039203116"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-08-04T17:05", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220804/entities/gbq_results/article/article_754.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1186/s13256-016-1180-4"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s13256-016-1180-4'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s13256-016-1180-4'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s13256-016-1180-4'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s13256-016-1180-4'


 

This table displays all metadata directly associated to this object as RDF triples.

287 TRIPLES      21 PREDICATES      131 URIs      120 LITERALS      20 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s13256-016-1180-4 schema:about N0b23e438397046979b2d784d9e57da0c
2 N24f931c2c63f467b85b3adfad2743ec0
3 N2637e08c6f0b4d49b07cef0813cf9083
4 N471b544040ad40d8a78bcd2a0151b347
5 N518660cac4164813ad0ded25e4ba0e33
6 N58768af80b84467a9f621435a93449d4
7 N87a1960bc08f4fbba930a89151363628
8 N9196e17356984250bd03ced7050971f8
9 N953f7f76199b4bf28b2ff0fe431e2805
10 N9aef457396dc47a9b359abe785f29ca4
11 Nafedbc918f7043839a885bba6786447e
12 Nbd01f41e6f3a400892dc501bca38e602
13 Ne93ea5b910134d11acf2f8c901029c04
14 anzsrc-for:11
15 anzsrc-for:1112
16 schema:author Ne4143edc1de2495f8e3ba8b2dd4577c9
17 schema:citation sg:pub.10.1007/s10549-006-9460-0
18 sg:pub.10.1038/nrclinonc.2010.154
19 sg:pub.10.1186/1757-1626-3-4
20 schema:datePublished 2017-01-10
21 schema:datePublishedReg 2017-01-10
22 schema:description BackgroundSurvival is increasing after early breast cancer revealing frequent relapses and possibility of developing secondary malignancies. The concomitant occurrence of these two events is exceptionally disastrous and lethal. We report a case of a Moroccan woman who was successfully managed for synchronous recurrent breast carcinoma and chronic myelogenous leukemia.Case presentationA 42-year-old Moroccan woman was diagnosed with localized breast carcinoma in 2008. She received six cycles of an adjuvant chemotherapy regimen, radiation therapy and hormonal therapy by tamoxifen. After completion of 5 years of tamoxifen our patient reported asthenia; a physical examination found hepatomegaly, massive splenomegaly measuring 21 cm and supraclavicular lymphadenopathy. The staging showed lung and liver metastases. Morphology and immunohistochemical profile of this metastasis identified an adenocarcinoma of mammary origin. In parallel, the diagnosis of chronic myeloid leukemia was suspected because of the presence of a leukocytosis at 355 × 109/L, with circulating blasts of 4%. Chronic myeloid leukemia was confirmed by a bone marrow biopsy with the presence of Ph chromosome on cytogenetical analysis.Daily imatinib was ordered concurrently with chemotherapy-type docetaxel. The metastases were stable after nine courses of chemotherapy. Due to breast cancer progression 4 months later, bevacizumab and capecitabine were introduced.A major molecular response was achieved after 12 and 18 months. She has now completed 2 years of follow-up, still on a major molecular response, and is undergoing imatinib and capecitabine treatment.ConclusionsLeukocytosis in breast cancer patients can reveal chronic myeloid leukemia. It may warrant a workup to find the underlying etiology, which could include a secondary hematological malignancy.
23 schema:genre article
24 schema:isAccessibleForFree true
25 schema:isPartOf N21c3d1bcccc64732a9e5a6223239f78b
26 Nfaef4cba06274c27a696ef2755f248d1
27 sg:journal.1038062
28 schema:keywords BackgroundSurvival
29 Case presentationA
30 Moroccan women
31 Ph chromosome
32 adenocarcinoma
33 adjuvant chemotherapy regimen
34 analysis
35 asthenia
36 bevacizumab
37 biopsy
38 blasts
39 bone marrow biopsy
40 breast cancer
41 breast cancer patients
42 breast carcinoma
43 cancer
44 cancer patients
45 capecitabine
46 capecitabine treatment
47 carcinoma
48 case report
49 cases
50 chemotherapy
51 chemotherapy regimen
52 chromosomes
53 chronic myelogenous leukemia
54 chronic myeloid leukemia
55 completion
56 concomitant occurrence
57 course
58 courses of chemotherapy
59 cycle
60 cytogenetical analysis
61 daily imatinib
62 diagnosis
63 docetaxel
64 early breast cancer
65 etiology
66 events
67 examination
68 frequent relapses
69 hematological malignancies
70 hepatomegaly
71 hormonal therapy
72 imatinib
73 immunohistochemical profile
74 leukemia
75 leukocytosis
76 liver metastases
77 lung
78 lymphadenopathy
79 major molecular response
80 malignancy
81 mammary origin
82 management
83 marrow biopsy
84 massive splenomegaly
85 metastasis
86 molecular response
87 months
88 morphology
89 myelogenous leukemia
90 myeloid leukemia
91 occurrence
92 origin
93 parallel
94 patients
95 physical examination
96 possibility
97 presence
98 profile
99 radiation therapy
100 recurrent breast carcinoma
101 regimen
102 relapse
103 report
104 response
105 secondary hematological malignancies
106 secondary malignancies
107 splenomegaly
108 staging
109 successful management
110 supraclavicular lymphadenopathy
111 tamoxifen
112 therapy
113 treatment
114 women
115 workup
116 years
117 years of tamoxifen
118 schema:name Successful management of synchronous recurrent breast carcinoma with chronic myelogenous leukemia: a case report
119 schema:pagination 10
120 schema:productId N046ef945922246259eede17f2f949739
121 N09325d70e9ea41369cafc7737e3e157b
122 Na262bea9477c47e3b2a6a818e28a73a5
123 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039203116
124 https://doi.org/10.1186/s13256-016-1180-4
125 schema:sdDatePublished 2022-08-04T17:05
126 schema:sdLicense https://scigraph.springernature.com/explorer/license/
127 schema:sdPublisher N9c2e67268cd447efbc0eac54a05caad0
128 schema:url https://doi.org/10.1186/s13256-016-1180-4
129 sgo:license sg:explorer/license/
130 sgo:sdDataset articles
131 rdf:type schema:ScholarlyArticle
132 N046ef945922246259eede17f2f949739 schema:name pubmed_id
133 schema:value 28069070
134 rdf:type schema:PropertyValue
135 N09325d70e9ea41369cafc7737e3e157b schema:name dimensions_id
136 schema:value pub.1039203116
137 rdf:type schema:PropertyValue
138 N0b23e438397046979b2d784d9e57da0c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
139 schema:name Adult
140 rdf:type schema:DefinedTerm
141 N0c15973d2dca4fa4929d06c077246a30 rdf:first sg:person.01306745267.40
142 rdf:rest Nf3180b3b73ee4bb2b5b90a00d7b74600
143 N168ffc7d0e454248b3c4701b4693575b rdf:first sg:person.01057303445.83
144 rdf:rest Nc6f8cf5250fb4dac9921da10b21ee7df
145 N21c3d1bcccc64732a9e5a6223239f78b schema:issueNumber 1
146 rdf:type schema:PublicationIssue
147 N24f931c2c63f467b85b3adfad2743ec0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name Chemotherapy, Adjuvant
149 rdf:type schema:DefinedTerm
150 N2637e08c6f0b4d49b07cef0813cf9083 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
151 schema:name Treatment Outcome
152 rdf:type schema:DefinedTerm
153 N2e43416d006544d2bed547db25932cce rdf:first sg:person.015315714724.06
154 rdf:rest rdf:nil
155 N471b544040ad40d8a78bcd2a0151b347 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
156 schema:name Taxoids
157 rdf:type schema:DefinedTerm
158 N518660cac4164813ad0ded25e4ba0e33 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
159 schema:name Female
160 rdf:type schema:DefinedTerm
161 N58768af80b84467a9f621435a93449d4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
162 schema:name Humans
163 rdf:type schema:DefinedTerm
164 N84c6911400794b1f80a0f4ff05142129 rdf:first sg:person.01273516024.18
165 rdf:rest N168ffc7d0e454248b3c4701b4693575b
166 N87a1960bc08f4fbba930a89151363628 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
167 schema:name Imatinib Mesylate
168 rdf:type schema:DefinedTerm
169 N9196e17356984250bd03ced7050971f8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
170 schema:name Docetaxel
171 rdf:type schema:DefinedTerm
172 N953f7f76199b4bf28b2ff0fe431e2805 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
173 schema:name Neoplasm Recurrence, Local
174 rdf:type schema:DefinedTerm
175 N9aef457396dc47a9b359abe785f29ca4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
176 schema:name Breast Neoplasms
177 rdf:type schema:DefinedTerm
178 N9c2e67268cd447efbc0eac54a05caad0 schema:name Springer Nature - SN SciGraph project
179 rdf:type schema:Organization
180 Na262bea9477c47e3b2a6a818e28a73a5 schema:name doi
181 schema:value 10.1186/s13256-016-1180-4
182 rdf:type schema:PropertyValue
183 Nafedbc918f7043839a885bba6786447e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
184 schema:name Leukemia, Myelogenous, Chronic, BCR-ABL Positive
185 rdf:type schema:DefinedTerm
186 Nbd01f41e6f3a400892dc501bca38e602 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
187 schema:name Capecitabine
188 rdf:type schema:DefinedTerm
189 Nc35202c06e434f00acc497fab37a111f rdf:first sg:person.01064507530.79
190 rdf:rest Nd68c9063e6e24416a121dd0c77c5f052
191 Nc39230e9d3b845028cb6205f5b6c6645 rdf:first sg:person.0755507243.30
192 rdf:rest N84c6911400794b1f80a0f4ff05142129
193 Nc6f8cf5250fb4dac9921da10b21ee7df rdf:first sg:person.01307760445.85
194 rdf:rest Nc35202c06e434f00acc497fab37a111f
195 Nd68c9063e6e24416a121dd0c77c5f052 rdf:first sg:person.01105351647.11
196 rdf:rest N2e43416d006544d2bed547db25932cce
197 Ne4143edc1de2495f8e3ba8b2dd4577c9 rdf:first sg:person.01050464377.90
198 rdf:rest N0c15973d2dca4fa4929d06c077246a30
199 Ne93ea5b910134d11acf2f8c901029c04 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
200 schema:name Antineoplastic Combined Chemotherapy Protocols
201 rdf:type schema:DefinedTerm
202 Nf3180b3b73ee4bb2b5b90a00d7b74600 rdf:first sg:person.0610414050.24
203 rdf:rest Nc39230e9d3b845028cb6205f5b6c6645
204 Nfaef4cba06274c27a696ef2755f248d1 schema:volumeNumber 11
205 rdf:type schema:PublicationVolume
206 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
207 schema:name Medical and Health Sciences
208 rdf:type schema:DefinedTerm
209 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
210 schema:name Oncology and Carcinogenesis
211 rdf:type schema:DefinedTerm
212 sg:journal.1038062 schema:issn 1752-1947
213 schema:name Journal of Medical Case Reports
214 schema:publisher Springer Nature
215 rdf:type schema:Periodical
216 sg:person.01050464377.90 schema:affiliation grid-institutes:None
217 schema:familyName Elm’hadi
218 schema:givenName Choukri
219 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01050464377.90
220 rdf:type schema:Person
221 sg:person.01057303445.83 schema:affiliation grid-institutes:None
222 schema:familyName Allaoui
223 schema:givenName Mohammed
224 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01057303445.83
225 rdf:type schema:Person
226 sg:person.01064507530.79 schema:affiliation grid-institutes:None
227 schema:familyName Messaoudi
228 schema:givenName Nezha
229 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01064507530.79
230 rdf:type schema:Person
231 sg:person.01105351647.11 schema:affiliation grid-institutes:None
232 schema:familyName Errihani
233 schema:givenName Hassan
234 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01105351647.11
235 rdf:type schema:Person
236 sg:person.01273516024.18 schema:affiliation grid-institutes:None
237 schema:familyName Mahtat
238 schema:givenName ElMehdi
239 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01273516024.18
240 rdf:type schema:Person
241 sg:person.01306745267.40 schema:affiliation grid-institutes:None
242 schema:familyName Khmamouche
243 schema:givenName Mohamed Reda
244 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01306745267.40
245 rdf:type schema:Person
246 sg:person.01307760445.85 schema:affiliation grid-institutes:None
247 schema:familyName Oukabli
248 schema:givenName Mohammed
249 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01307760445.85
250 rdf:type schema:Person
251 sg:person.015315714724.06 schema:affiliation grid-institutes:None
252 schema:familyName Ichou
253 schema:givenName Mohammed
254 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015315714724.06
255 rdf:type schema:Person
256 sg:person.0610414050.24 schema:affiliation grid-institutes:None
257 schema:familyName Tanz
258 schema:givenName Rachid
259 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0610414050.24
260 rdf:type schema:Person
261 sg:person.0755507243.30 schema:affiliation grid-institutes:None
262 schema:familyName Toreis
263 schema:givenName Mehdi
264 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0755507243.30
265 rdf:type schema:Person
266 sg:pub.10.1007/s10549-006-9460-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000430722
267 https://doi.org/10.1007/s10549-006-9460-0
268 rdf:type schema:CreativeWork
269 sg:pub.10.1038/nrclinonc.2010.154 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008665386
270 https://doi.org/10.1038/nrclinonc.2010.154
271 rdf:type schema:CreativeWork
272 sg:pub.10.1186/1757-1626-3-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038578733
273 https://doi.org/10.1186/1757-1626-3-4
274 rdf:type schema:CreativeWork
275 grid-institutes:None schema:alternateName Clinical Hematology Department, Mohammed V Military Teaching Hospital of Rabat, Rabat, Morocco
276 Department of Pathology, Mohammed V Military Teaching Hospital of Rabat, Rabat, Morocco
277 Laboratory of Hematology, Mohammed V Military Teaching Hospital of Rabat, Rabat, Morocco
278 Medical Oncology Department, Mohammed V Military Teaching Hospital of Rabat, Rabat, Morocco
279 Medical Oncology Department, National Institute of Oncology Sidi Mohamed Ben Abdellah, Rabat, Morocco
280 School of Medicine and Pharmacy, University Mohamed V, Souissi, Rabat, Morocco
281 schema:name Clinical Hematology Department, Mohammed V Military Teaching Hospital of Rabat, Rabat, Morocco
282 Department of Pathology, Mohammed V Military Teaching Hospital of Rabat, Rabat, Morocco
283 Laboratory of Hematology, Mohammed V Military Teaching Hospital of Rabat, Rabat, Morocco
284 Medical Oncology Department, Mohammed V Military Teaching Hospital of Rabat, Rabat, Morocco
285 Medical Oncology Department, National Institute of Oncology Sidi Mohamed Ben Abdellah, Rabat, Morocco
286 School of Medicine and Pharmacy, University Mohamed V, Souissi, Rabat, Morocco
287 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...